Alejandra Carvajal, SVP, Chief Legal Officer at Mersana Therapeutics, Inc. (MRSN), sold 13,687 shares at $2.00 ($27K) on 2024-10-02, disclosed to the SEC on 2024-10-07.
Scheduled sale ($27k) by SVP, Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.00 | 8,089 | $16K | 59.6% |
| 2 | $1.96 | 5,598 | $11K | 40.4% |
| Total | $1.98 avg | 13,687 | $27K | 100% |
| Filing → |
| MRSN | SELL | 2025-01-15 | $2K | — | Filing → |
| MRSN | SELL | 2024-01-17 | $12K | — | Filing → |
| MRSN | SELL | 2023-04-28 | $15K | — | Filing → |